SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-453357
Filing Date
2012-11-06
Accepted
2012-11-06 09:16:01
Documents
10
Period of Report
2012-09-30
Filing Date Changed
2012-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398548d10q.htm 10-Q 484975
2 EX-31.1 d398548dex311.htm EX-31.1 8129
3 EX-31.2 d398548dex312.htm EX-31.2 8040
4 EX-32.1 d398548dex321.htm EX-32.1 4432
  Complete submission text file 0001193125-12-453357.txt   2710071

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT geva-20120930.xml EX-101.INS 325382
6 XBRL TAXONOMY EXTENSION SCHEMA geva-20120930.xsd EX-101.SCH 29528
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20120930_cal.xml EX-101.CAL 42564
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20120930_def.xml EX-101.DEF 44824
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20120930_lab.xml EX-101.LAB 202895
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20120930_pre.xml EX-101.PRE 144468
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23155 | Film No.: 121181863
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1